AHRQ Updates Review on Therapies for Clinically Localized Prostate Cancer

AHRQ has released an update of a 2008 research review on therapies for clinically localized prostate cancer. According to the review, more evidence is needed to evaluate comparative risks and benefits of therapies. The findings are similar to those in the 2008 review, which found that no single therapy can be considered the preferred treatment for localized prostate cancer because of limitations in the body of evidence as well as the likely tradeoffs a patient must make between estimated treatment effectiveness, necessity and adverse effects. The full report and executive summary of “Therapies for Clinically Localized Prostate Cancer: Update of a 2008 Systematic Review,” are available on AHRQ’s Effective Health Care Program website.